BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 4, 2026
Home » Authors » Anette Breindl

Articles by Anette Breindl

Progress, setbacks in understanding tau

July 29, 2016
By Anette Breindl
Antibodies aimed at the protein tau, which accumulates during the later stages of Alzheimer’s disease (AD), do not need to engage immune cells to clear the protein, and they were less toxic to neurons in cell culture experiments than antibodies that did bind to immune cells as well as tau.
Read More

Hard-nosed bacteria produce antibiotics against their neighbors

July 28, 2016
By Anette Breindl
A team from the University of Tuebingen has identified the first bactericidal compound produced by a member of the human microbiome.
Read More

'Nottingham Dollies' collectively aging well, study report shows

July 27, 2016
By Anette Breindl

'Nottingham Dollies' collectively aging well, study reports

July 27, 2016
By Anette Breindl
Comprehensive health assessment of a group of 13 cloned sheep, including the "Nottingham Dollies," four sheep that were created from the same cell line as Dolly the Sheep, has shown that, as a group, the animals were no more prone to health problems than naturally conceived sheep of the same age.
Read More

Bench Press: BioWorld looks at translational medicine

July 25, 2016
By Anette Breindl
Scientists from the NIH have identified mechanisms by which HIV persists in different anatomical locations.
Read More

Old patients with HIV are the newest group with unique needs

July 22, 2016
By Anette Breindl

Old patients with HIV are the new group with unique needs

July 22, 2016
By Anette Breindl
DURBAN, South Africa – In the early days of the AIDS epidemic, the life expectancy for those diagnosed with HIV was two years from the time of diagnosis.
Read More

Tuberculosis is getting attention; will new vaccines, drugs follow?

July 21, 2016
By Anette Breindl

Tuberculosis is getting attention; will new vaccines, drugs follow?

July 21, 2016
By Anette Breindl
DURBAN, South Africa – "When people learn that tuberculosis is airborne, that it kills millions of people, that drug resistance is spreading, watch their reaction – they do not think that TB is boring anymore," Jose Luis Castro, executive director of the International Union Against Tuberculosis and Lung Disease, told the audience at the 2016 international AIDS conference.
Read More

The search for a broadly useful HIV cure continues

July 20, 2016
By Anette Breindl
Previous 1 2 … 167 168 169 170 171 172 173 174 175 … 401 402 Next

Popular Stories

  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • University of Western Australia patents 5-HT2A/B modulators

    BioWorld Science
    University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
  • Neurons

    AA meeting of minds as PTC, Novartis push votoplam in HD

    BioWorld
    What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
  • Nerves within a melanoma tumor

    Innervation can slow, as well as speed, tumor growth, study finds

    BioWorld
    Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
  • Alceptor Therapeutics discovers new α2B-adrenoceptor agonists

    BioWorld Science
    Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing